English
Polski
Español
українська
Management of MI depending on age
Should the management of myocardial infarction (MI) vary depending on the patient’s age?
2020-04-03
Should the management of myocardial infarction (MI) vary depending on the patient’s age?
What is the current approach to the treatment of hypertension in elderly patients?
Should revascularization procedures in chronic limb ischemia be limited in older patients depending on their age or performance status?
Is there still a role for creatine kinase (CK) or creatine kinase–myocardial band (CK-MB) in a patient with suspected myocardial infarction (MI)?
When should we start pharmacotherapy in young patients with hypertension and no other cardiovascular risk factors?
Is there still a place for beta-blockers in the treatment of hypertension?
When should a patient with symptoms of peripheral artery disease (PAD) be referred for interventional or surgical treatment?
What should be the duration of dual antiplatelet therapy in patients after percutaneous coronary interventions (PCIs)?
What is the current role of anticoagulation in patients with peripheral artery disease (PAD)?
Why was the new definition of myocardial infarction (MI) necessary? What have we learned about MI since the third definition?
